Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
37104 POSTS 0 COMMENTS
Most patients with atrial fibrillation (AF) and systolic heart failure who undergo ablation have AF recurrence at five years

A-Fib Recurrence Common Five Years After Ablation

0
For patients with a-fib and heart failure, mortality rates lower after ablation versus no ablation
Medical students in personal distress may be more likely to have suboptimal attitudes about self-prescribing and personal responsibility for reporting impaired colleagues

Suboptimal Prescribing Attitudes Could Signal Personal Distress

0
Med students experiencing depression, alcohol abuse less likely to report impaired colleagues
Phenytoin appears to be neuroprotective in acute optic neuritis

AAN: Phenytoin Neuroprotective in Optic Neuritis

0
Adjusted eye retinal nerve fiber layer thickness higher for those receiving phenytoin versus placebo
For patients with Behçet's syndrome

Apremilast Effective for Oral Ulcers in Behçet’s Syndrome

0
Reduction in number of oral ulcers per patient; greater decline in pain from ulcers with apremilast
For clinically atypical pigmented lesions

Review Compares Shave, Punch Biopsy Methods

0
No difference in rate of overall positive margins for all lesions; size, morphology impact positivity
Hydration during primary percutaneous coronary intervention is associated with a reduction in the risk of contrast-induced nephropathy

Hydration During PCI Cuts Risk of Contrast-Induced Nephropathy

0
CIN significantly associated with mortality and need for dialysis; hydration is predictor of CIN
Hydroxychloroquine appears to be associated with lower risk of hyperlipidemia in patients with early rheumatoid arthritis

Hydroxychloroquine May Reduce Hyperlipidemia Risk in Early RA

0
Reduced risk of hyperlipidemia with hydroxychloroquine versus other DMARDs
The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food and Drug Administration to treat multiple sclerosis.

FDA: Generic Copaxone Approved for Multiple Sclerosis

0
FDA reviewed additional information to ensure generic is as safe and effective as brand-name drug
Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure

FDA Approves Corlanor for Chronic Heart Failure

0
Works by decreasing heart rate; first approved product in this drug class
Anti-inflammatories may help prevent many neuropathologic effects of Lyme neuroborreliosis

More Evidence Implicates Inflammation in Lyme Neuro Dz

0
Study in rhesus macaques indicates causal role for inflammation in Lyme neuroborreliosis